In addition to a panel of gene analysis of the tumour, mutation analysis of the BRAF, KRAS and NRAS genes and Mismatch Repair (MMR) status (Microsatellite instability, MSI, Immunohistochemistry, IHC, for MMR genes) will be performed on the selected tumour sections. This evidence concerns the gene MRC1 and neoplasm.